Skip to main content

Advertisement

Log in

Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Fusarium species are ubiquitously present in environment and are well known as human pathogens with high mortality rate in immunocompromised patients. We report here two cases where immunocompromised patients developed fatal bloodstream infections by this organism. Isolates were further identified by ITS1 region sequencing which confirmed them as Fusarium solani. Antifungal susceptibility testing was done following CLSI M38-A2 guidelines to amphotericin B, fluconazole, itraconazole, voriconazole, posaconazole, caspofungin, and micafungin. Both patients had a fatal outcome and expired of septic shock. Therefore, identification up to species level is of utmost importance as that helps in directing the management of the patient thereby leading to a favourable outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother. 2011;66:i5–i14.

    Article  CAS  PubMed  Google Scholar 

  2. Enoch DA, Ludlam HA, Brown NM. Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol. 2006;55:809–18.

    Article  CAS  PubMed  Google Scholar 

  3. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695–704.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Marie C, White TC. Genetic basis of antifungal drug resistance. Curr Fungal Infect Rep. 2009;3:163–9. doi:10.1007/s12281-009-0021-y.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev. 2011;24:247–80.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Healy M, Reece K, Walton D, Huong J, Frye S, Raad II, et al. Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol. 2005;43:5278–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006;50:917–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Espinel-Ingroff A, Chaturvedi V, Fothergill A, Rinaldi MG. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol. 2002;40:3776–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother. 2002;46:3298–300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mseddi F, Jarboui MA, Sellami A, Sellami H, Ayadi A. A rapid and easy method for the DNA extraction from Cryptococcus neoformans. Biol Proced Online. 2011;21:13–5.

    Google Scholar 

  11. Nucci M, Anaissie EJ, Queiroz-Telles F, Martins CA, Trabasso P, Solza C, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003;98:315–9.

    Article  PubMed  Google Scholar 

  12. Musa MO, Al Eisa A, Halim M, Sahovic E, Gyger M, Chaudhri N, et al. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol. 2000;108:544–8.

    Article  CAS  PubMed  Google Scholar 

  13. Tortorano AM, Esposto MC, Prigitano A, Grancini A, Ossi C, Cavanna C, et al. Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol. 2012;50:1051–3.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Raad II, Hachem RY, Herbrecht R, Graybill JR, Hare R, Corcoran G, et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006;42:1398–403.

    Article  CAS  PubMed  Google Scholar 

  15. Makowsky MJ, Warkentin DI, Savoie ML. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia. Ann Pharmacother. 2005;39:1365–6.

    Article  PubMed  Google Scholar 

  16. Durand-Joly I, Alfandari S, Benchikh Z, Rodrigue M, Espinel-Ingroff A, Catteau B, et al. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol. 2003;41:4898–900.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Guzman-Cottrill JA, Zheng X, Chadwick EG. Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr Infect Dis J. 2004;23:1059–61.

    Article  PubMed  Google Scholar 

  18. Rothe A, Seibold M, Hoppe T, Seifert H, Engert A, Caspar C, et al. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol. 2004;83:394–7.

    Article  CAS  PubMed  Google Scholar 

  19. Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis. 2003;22:111–3.

    CAS  PubMed  Google Scholar 

  20. Carneiro HA, Coleman JJ, Restrepo A, Mylonakis E. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine. 2011;90:69–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ersal T, Al-Hatmi ASM, Cilo BD, Curfs-Breuker I, Meis JF, Özkalemkaş F, et al. Fatal disseminated infection with Fusarium petroliphilum. Mycopathologia. 2015;179:119–24.

    Article  PubMed  Google Scholar 

  22. Dananché C, Cassier P, Sautour M, Gautheron N, Wegrzyn J, Perraud M, et al. Fungaemia caused by Fusarium proliferatum in a patient without definite immunodeficiency. Mycopathologia. 2015;179:135–40.

    Article  PubMed  Google Scholar 

  23. de Souza M, Matsuzawa T, Lyra L, Busso-Lopes AF, Gonoi T, Schreiber AZ, et al. Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests. Springerplus. 2014;3:492.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kang Y, Li L, Zhu J, Zhao Y, Zhang Q. Identification of Fusarium from a patient with fungemia after multiple organ injury. Mycopathologia. 2013;176:151–5.

    Article  PubMed  Google Scholar 

  25. Esnakula AK, Summers I, Naab TJ. Fatal disseminated Fusarium infection in a human immunodeficiency virus positive patient. Case Rep Infect Dis. 2013;2013:379320. doi:10.1155/2013/379320.

    PubMed  PubMed Central  Google Scholar 

  26. Colombo A, Maccari G, Congiu T, Basso P, Baj A, Toniolo A. Colonization of a central venous catheter by the hyaline fungus Fusarium solani species complex: a case report and SEM imaging. Case Rep Med. 2013;2013:618358. doi:10.1155/2013/618358.

    PubMed  PubMed Central  Google Scholar 

  27. Fanci R, Pini G, Bartolesi AM, Pecile P. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Rev Iberoam Micol. 2013;30:51–3. doi:10.1016/j.riam.2012.05.003.

    Article  PubMed  Google Scholar 

  28. Pereira GH, de Angelis DA, Brasil RA, dos Anjos Martins M, de Matos Castro e Silva D, Szeszs MW, et al. Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases. Mycopathologia. 2013;175:107–14.

    Article  PubMed  Google Scholar 

  29. Schwartz KL, Sheffield H, Richardson SE, Sung L, Morris SK. Invasive fusariosis: a single pediatric center 15-year experience. J Pediatr Infect Dis Soc. 2013;. doi:10.1093/jpids/pit080.

    Google Scholar 

  30. O’Connell K, Kelehan J, Cormican M, Petrou MA, Hayat A, Keady D. Breakthrough Fusarium solani fungaemia in a patient with acute myeloid leukaemia receiving posaconazole prophylaxis after three days concomitant omeprazole. Int J Case Rep Image. 2011;2:7–12.

    Article  Google Scholar 

  31. Jossi M, Ambrosioni J, Macedo-Vinas M, Garbino J. Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature. Int J Infect Dis. 2010;14:e354–6. doi:10.1016/j.ijid.2009.05.004.

    Article  CAS  PubMed  Google Scholar 

  32. Lodato F, Tamé MR, Montagnani M, Sambri V, Liguori G, Azzaroli F, et al. Systemic fungemia and hepatic localizations of Fusarium solani in a liver transplanted patient: an emerging fungal agent. Liver Transpl. 2006;12:1711–4.

    Article  PubMed  Google Scholar 

  33. Fang CT, Chang SC, Tang IL, Hsueh PR, Chang YL, Hung CC, et al. Fusarium solani fungemia in a bone marrow transplant recipient. J Formos Med Assoc. 1997;96:129–33.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Immaculata Xess.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dabas, Y., Bakhshi, S. & Xess, I. Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature. Mycopathologia 181, 291–296 (2016). https://doi.org/10.1007/s11046-015-9960-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-015-9960-8

Keywords

Navigation